Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Jan 14, 2023 12:17pm
343 Views
Post# 35223224

RE:RE:RE:RE:RE:Nice to see that there are NO---Gaps---below--

RE:RE:RE:RE:RE:Nice to see that there are NO---Gaps---below--
plantrader wrote: I believe they recently said they plan to APPLY for BTD sometime in Q1. That means sometime before the end of March. Then FDA has 60 days to respond. Not sure if FDA can also do some requests for clarification, back & forth, which could extend the 60 days? Or not. I'm trying to bed realistic with timeline expectations. A few months isn't so long compared to the past X years. 

Longholder99 wrote: I am having a hard time figuring it out.  But I think I bought my 1st thousand shares in 2012.  Haven't sold one since.  Only buys since that day.  Was it worth the long wait?  I would love to hear educated opinions on our timeline from here.  I just don't want to guess anymore.  




Which is why I'm thinking AA could happen in June/July. It really depends on when when the Phase 2 trial clinicians get around to doing the assessments?? I think once BTD is applied for we are looking at ~ 6 months total to AA.
<< Previous
Bullboard Posts
Next >>